1032279-33-6 Usage
General Description
7-methoxy-2,3-dihydro-1H-inden-1-amine is a chemical compound that falls under the category of organic compounds, specifically aromatic homomonocyclic compounds. It is also known as Indan-1-amine, 7-methoxy-2,3-dihydro-. 7-methoxy-2,3-dihydro-1H-inden-1-amine is known for its unique structure comprised of benzene fused to a cyclopentane, a structure lending it aromatic properties. It has not been widely studied, thus its potential applications or properties apart from its basic structure have not been extensively explored or exploited. Detailed safety and handling precautions are often not available for this specific compound. Its precise molecular formula is C10H13NO.
Check Digit Verification of cas no
The CAS Registry Mumber 1032279-33-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,2,2,7 and 9 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1032279-33:
(9*1)+(8*0)+(7*3)+(6*2)+(5*2)+(4*7)+(3*9)+(2*3)+(1*3)=116
116 % 10 = 6
So 1032279-33-6 is a valid CAS Registry Number.
1032279-33-6Relevant articles and documents
Synthesis and carbonic anhydrase inhibitory effects of novel sulfamides derived from 1-aminoindanes and anilines
Akbaba, Yusuf,Bastem, Enes,Topal, Fevzi,Gülin, Ilhami,Maras, Ahmet,G?ksu, Süleyman
, p. 950 - 957 (2014)
Three 1-aminoindanes, four anilines and BnOH or t-BuOH were reacted with chlorosulfonyl isocyanate to give sulfamoyl carbamates. Pd-C catalysed hydrogenolysis reactions of carbamates or deprotection of the Boc group of the carbamates with CF3CO2H afforded
2-AMINOQUINOLINES
-
Page/Page column 35, (2009/09/25)
The present invention is concerned with 2-aminoquinoline derivatives of formula I where R1, R2, R3, R4, R5, R6, A, and n are as defined in the specification and claims, their use 5-HT5
QUINOLINES
-
Page/Page column 27-29, (2008/12/06)
The present invention relates to 2-Aminoquinoline derivatives of general formula I and pharmaceutically-acceptable acid-addition salts thereof, wherein R1, R2 and X are as defined in the specification. The compounds may be used as 5-
